735 related articles for article (PubMed ID: 29602451)
1. [Autologous serum tears: Long-term treatment in dry eye syndrome].
Beylerian M; Lazaro M; Magalon J; Veran J; Darque A; Grimaud F; Stolowy N; Beylerian H; Sabatier F; Hoffart L
J Fr Ophtalmol; 2018 Mar; 41(3):246-254. PubMed ID: 29602451
[TBL] [Abstract][Full Text] [Related]
2. [Prospective, monocentric, uncontrolled study of efficacy, tolerance and adherence of cyclosporin 0.1 % for severe dry eye syndrome].
Boujnah Y; Mouchel R; El-Chehab H; Dot C; Burillon C; Kocaba V
J Fr Ophtalmol; 2018 Feb; 41(2):129-135. PubMed ID: 29449025
[TBL] [Abstract][Full Text] [Related]
3. Three percent diquafosol ophthalmic solution as an additional therapy to existing artificial tears with steroids for dry-eye patients with Sjögren's syndrome.
Yokoi N; Sonomura Y; Kato H; Komuro A; Kinoshita S
Eye (Lond); 2015 Sep; 29(9):1204-12. PubMed ID: 26160526
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of Autologous Serum Eye Drops Combined With Punctal Plugs for the Treatment of Sjögren Syndrome-Related Dry Eye.
Liu Y; Hirayama M; Cui X; Connell S; Kawakita T; Tsubota K
Cornea; 2015 Oct; 34(10):1214-20. PubMed ID: 26226470
[TBL] [Abstract][Full Text] [Related]
5. Treatment of severe chronic ocular graft-versus-host disease using 100% autologous serum eye drops from a sealed manufacturing system: a retrospective cohort study.
Tahmaz V; Gehlsen U; Sauerbier L; Holtick U; Engel L; Radojska S; Petrescu-Jipa VM; Scheid C; Hallek M; Gathof B; Cursiefen C; Steven P
Br J Ophthalmol; 2017 Mar; 101(3):322-326. PubMed ID: 27267447
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the effect of topical tacrolimus 0.03% versus cyclosporine 0.05% in the treatment of dry eye secondary to Sjogren syndrome.
Moawad P; Shamma R; Hassanein D; Ragab G; El Zawahry O
Eur J Ophthalmol; 2022 Jan; 32(1):673-679. PubMed ID: 33530719
[TBL] [Abstract][Full Text] [Related]
7. Association between systemic activity ındex and dry eye severity in patients with primary Sjögren syndrome.
Ozek D; Kemer OE; Omma A
Arq Bras Oftalmol; 2019; 82(1):45-50. PubMed ID: 30403265
[TBL] [Abstract][Full Text] [Related]
8. Autologous serum eye drops for the treatment of severe dry eye in patients with chronic graft-versus-host disease.
Ogawa Y; Okamoto S; Mori T; Yamada M; Mashima Y; Watanabe R; Kuwana M; Tsubota K; Ikeda Y; Oguchi Y
Bone Marrow Transplant; 2003 Apr; 31(7):579-83. PubMed ID: 12692625
[TBL] [Abstract][Full Text] [Related]
9. Comparison of autologous serum and umbilical cord serum eye drops for dry eye syndrome.
Yoon KC; Heo H; Im SK; You IC; Kim YH; Park YG
Am J Ophthalmol; 2007 Jul; 144(1):86-92. PubMed ID: 17493572
[TBL] [Abstract][Full Text] [Related]
10. [A 0,05% cyclosporine treatment of the advanced dry eye syndrome].
Kujawa A; Rózycki R
Klin Oczna; 2005; 107(4-6):280-6. PubMed ID: 16118939
[TBL] [Abstract][Full Text] [Related]
11. [Comparison of objective optical quality measured by double-pass aberrometry in patients with moderate dry eye: Normal saline vs. artificial tears: A pilot study].
Vandermeer G; Chamy Y; Pisella PJ
J Fr Ophtalmol; 2018 Mar; 41(3):238-245. PubMed ID: 29573863
[TBL] [Abstract][Full Text] [Related]
12. Sjögren's Syndrome, Non-Sjögren's Syndrome, and Graft-Versus-Host Disease Related Dry Eye.
Ogawa Y
Invest Ophthalmol Vis Sci; 2018 Nov; 59(14):DES71-DES79. PubMed ID: 30481809
[TBL] [Abstract][Full Text] [Related]
13. Allogeneic serum eye drops for the treatment of dry eye patients with chronic graft-versus-host disease.
Na KS; Kim MS
J Ocul Pharmacol Ther; 2012 Oct; 28(5):479-83. PubMed ID: 22731244
[TBL] [Abstract][Full Text] [Related]
14. [Comparison of two kinds of artificial tears on the dry eye after phacoemulsification].
You R; Wang J; Han Y; Liu LJ; Wang WY
Zhonghua Yan Ke Za Zhi; 2017 Jun; 53(6):445-450. PubMed ID: 28606267
[No Abstract] [Full Text] [Related]
15. [Gas-permeable scleral lens for management of severe keratoconjunctivitis sicca secondary to chronic graft-versus-host disease].
Rossi P; Delcampe A; Gueudry J; Duncombe A; Gabison E; Doan S; Muraine M
J Fr Ophtalmol; 2015 Nov; 38(9):793-9. PubMed ID: 26456486
[TBL] [Abstract][Full Text] [Related]
16. Serum eye drops for the treatment of ocular surface diseases: a systematic review and meta-analysis.
Franchini M; Cruciani M; Mengoli C; Marano G; Capuzzo E; Pati I; Masiello F; Veropalumbo E; Pupella S; Vaglio S; Liumbruno GM
Blood Transfus; 2019 May; 17(3):200-209. PubMed ID: 31246562
[TBL] [Abstract][Full Text] [Related]
17. The Efficacy of Diquafosol Ophthalmic Solution in Non-Sjögren and Sjögren Syndrome Dry Eye Patients Unresponsive to Artificial Tear.
Jeon HS; Hyon JY
J Ocul Pharmacol Ther; 2016 Sep; 32(7):463-8. PubMed ID: 27294831
[TBL] [Abstract][Full Text] [Related]
18. [Treating severe dry eye syndromes with autologous serum].
Creuzot-Garcher C; Lafontaine PO; Brignole F; Pisella PJ; d'Athis P; Bron A; Lapierre V; Baudouin C
J Fr Ophtalmol; 2004 Apr; 27(4):346-51. PubMed ID: 15173640
[TBL] [Abstract][Full Text] [Related]
19. Analysis of the first tear film break-up point in Sjögren's syndrome and non-Sjögren's syndrome dry eye patients.
Zhao S; Le Q
BMC Ophthalmol; 2022 Jan; 22(1):1. PubMed ID: 34980014
[TBL] [Abstract][Full Text] [Related]
20. Effect of Autologous Serum Eye Drops in Patients with Sjögren Syndrome-related Dry Eye: Clinical and In Vivo Confocal Microscopy Evaluation of the Ocular Surface.
Semeraro F; Forbice E; Nascimbeni G; Taglietti M; Romano V; Guerra G; Costagliola C
In Vivo; 2016 11-12; 30(6):931-938. PubMed ID: 27815483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
